Epidemiologic evidence supports the role of PSA screening in the stage and grade migration of prostate cancer, but to date the evidence for its role in changing mortality patterns is more equivocal.

There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

Biomerica's Fortel PSA test gains UAE approval for prostate cancer detection. Q2 shows 5% sales growth and reduced losses through cost optimization.

Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously ... Dec. 19, 2024 — There are several ...

Jan. 15, 2025 – Prostate cancer is quite common – nearly 60% of men over 65 have it – but it’s not a high priority for cancer researchers. One big reason: Most men with prostate cancer ...

Prostate cancer remains one of the most prevalent cancers affecting men worldwide. While this disease often develops gradually without obvious symptoms in its earliest stages, understanding and ...

The screenings included 250 skin cancer screenings, 35 Prostate-Specific Antigen (PSA) screenings, nine lung cancer screenings, and five Cologuard screenings. Centra’s modernization update ...